Information Library
Targeted communications - Thought leadership
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
The Value of CROs
March 31, 2009
Contract Research Organizations (CROs) are making an increasingly valuable contribution to healthcare by conducting the clinical trials that help determine which investigational medicines advance toward regulatory approval. -
Championing the Clinical Trial
March 31, 2009
Quintiles’ ethical standards and review procedures ensure patient safety remains the top priority for all clinical trials. The company is also leading the way for data transparency, so drug trial sponsors have instant access to information about the conduct and status of trials. -
Advancing Drug Development Through Pharmacogenomics
March 31, 2009
Pharmacogenomics (PG x) is the study of how such genetic differences influence drug therapy. The goal is to use a person’s DNA profile to predict how the individual will respond to a medicine. The ability to predict drug response holds enormous promise to advance the drug development process and to improve drug safety and effectiveness in medical practice.
Page 1 of 1 (3 items)